J&J speculation lifts Smith & Nephew

J&J speculation lifts Smith & Nephew

One of the UK market’s most habitual takeover rumours returned again on September 21, with shares in Smith & Nephew rising by around 2.5% in a couple of hours as renewed speculation gained traction.

According to Acquisitions Daily, Smith & Nephew has long been a favourite target of speculators with its world leading position in some of the less heavily regulated parts of the healthcare market seen as attractive and the company’s approximately £10bn capitalisation seen as easily affordable for a number of American companies. Stryker and Medtronic have periodically been…